Propanc Biopharma Receives Certificate of Grant for “Composition of Proenzymes for Cancer Treatment” Patent

MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that a certificate of grant for the Company’s “composition of proenzymes for cancer treatment,” patent was received from the European Patent Office. The patent covers lower …

In a significant development for Propanc Biopharma, the Company has been granted a patent for their innovative “Composition of Proenzymes for Cancer Treatment” by the European Patent Office. This patent is a major milestone for the Company as it recognizes the unique and groundbreaking approach Propanc is taking in the field of cancer treatment.

The Propanc team has been dedicated to developing novel therapies that can make a real difference in the lives of patients suffering from recurring and metastatic cancer. This patent grant is a testament to their hard work and dedication, and solidifies Propanc’s position as a leader in the biopharmaceutical industry.

Impact on Individuals:

For individuals battling cancer, this patent grant represents hope for more effective and targeted treatment options. Propanc’s innovative approach to cancer therapy could potentially lead to better outcomes and improved quality of life for patients facing this devastating disease.

Impact on the World:

The granting of this patent is not only a win for Propanc Biopharma, but also for the global fight against cancer. By developing new and effective treatments, Propanc is contributing to the larger effort to improve cancer care and ultimately find a cure for this widespread illness.

Conclusion

The receipt of the certificate of grant for the “Composition of Proenzymes for Cancer Treatment” patent is a significant achievement for Propanc Biopharma and a positive step forward in the fight against cancer. This patent not only recognizes the innovation and dedication of the Propanc team, but also holds great promise for individuals battling cancer and the global community working to eradicate this disease.